Company profile
KinCon biolabs company profile
KinCon biolabs develops live-cell biosensors to measure protein activity in cells. Their technology tracks changes in protein shape caused by drugs under physiological conditions. It integrates patient-specific mutations into biosensors to test how drugs work on these variants. The company supports drug development, especially for diseases involving mutated enzymes.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2022-03-01, Month
Headquarters
- Headquarters
- Innsbruck, Tyrol, Austria
- Postal code
- 6020
- Country code
- AT
- Continent
- Europe